Cosyntropin stimulation in adrenal vein sampling improves the judgment of successful adrenal vein catheterization and outcome prediction for primary aldosteronism.


Journal

Hypertension research : official journal of the Japanese Society of Hypertension
ISSN: 1348-4214
Titre abrégé: Hypertens Res
Pays: England
ID NLM: 9307690

Informations de publication

Date de publication:
10 2020
Historique:
received: 08 10 2019
accepted: 31 03 2020
revised: 09 03 2020
pubmed: 2 5 2020
medline: 8 10 2021
entrez: 2 5 2020
Statut: ppublish

Résumé

The importance of cosyntropin stimulation during adrenal vein sampling (AVS) is not fully established, partly due to insufficient AVS data relating the presence and absence of cosyntropin stimulation with postoperative outcome. Therefore, we investigated differences in AVS indices before and after cosyntropin stimulation, and determined whether unstimulated or stimulated AVS indices better correlated with treatment outcome. A retrospective study was conducted in two parts: one with 185 patients who underwent AVS and the other with 81 patients who underwent unilateral adrenalectomy for unilateral aldosterone oversecretion. The selectivity index (SI), lateralized ratio (LR), and contralateral ratio (CR) before and after cosyntropin stimulations were determined, along with blood pressure outcome 1 year after surgery. Primary aldosteronism was diagnosed according to the Japanese Endocrine Society 2009 guidelines. The percentage of AVS patients with successful catheterization, defined as unstimulated SI > 2 before and stimulated SI > 5, increased after cosyntropin stimulation from 52% to 93% and from 74% to 98% for the right and left adrenal veins, respectively. LR decreased after cosyntropin stimulation (P < 0.001). In the postoperative patients, complete and partial clinical success was achieved in 49 and 27%, respectively. Low CR (<1) and high LR (≥2.6) after cosyntropin stimulation better correlated with postoperative blood pressure outcome than those before stimulation (CR < 1 and LR ≥ 2). These data suggest that cosyntropin stimulation facilitated the judgment of catheter insertion and postcosyntropin AVS indices may be more useful for predicting treatment outcome after unilateral adrenalectomy. Further study should examine the usefulness of cosyntropin stimulation in AVS performed in other settings.

Identifiants

pubmed: 32355223
doi: 10.1038/s41440-020-0445-x
pii: 10.1038/s41440-020-0445-x
doi:

Substances chimiques

Cosyntropin 16960-16-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1105-1112

Références

Rossi GP, Auchus RJ, Brown M, Lenders JW, Naruse M, Plouin PF, et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension 2014;63:151–60.
pubmed: 24218436 pmcid: 24218436
Rossi GP, Barisa M, Allolio B, Auchus RJ, Amar L, Cohen D, et al. The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism. J Clin Endocrinol Metab. 2012;97:1606–14.
pubmed: 22399502 pmcid: 22399502
Bardet S, Chamontin B, Douillard C, Pagny JY, Hernigou A, Joffre F, et al. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 4: Subtype diagnosis. Ann Endocrinol (Paris). 2016;77:208–13.
Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, et al. Guidelines for the diagnosis and treatment of primary aldosteronism-the Japan Endocrine Society 2009. Endocr J. 2011;58:711–21.
pubmed: 21828936 pmcid: 21828936
The Japan Society of Endocrinology. Consensus statement on the clinical practice of primary aldosteronism in Japan. Folia Endocrinol Jpn. 2016;92.
Amar L, Baguet JP, Bardet S, Chaffanjon P, Chamontin B, Douillard C, et al. SFE/SFHTA/AFCE primary aldosteronism consensus: introduction and handbook. Ann Endocrinol (Paris). 2016;77:179–86.
Tanemoto M, Suzuki T, Abe M, Abe T, Ito S. Physiologic variance of corticotropin affects diagnosis in adrenal vein sampling. Eur J Endocrinol. 2009;160:459–63.
pubmed: 19050165 pmcid: 19050165
Nakamura Y, Satoh F, Morimoto R, Kudo M, Takase K, Gomez-Sanchez CE, et al. 18-oxocortisol measurement in adrenal vein sampling as a biomarker for subclassifying primary aldosteronism. J Clin Endocrinol Metab. 2011;96:E1272–8.
pubmed: 21593107 pmcid: 21593107
Laurent I, Astère M, Zheng F, Chen X, Yang J, Cheng Q, et al. Adrenal venous sampling with or without adrenocorticotropic hormone stimulation: a meta-analysis. J Clin Endocrinol Metab. 2018;104:1060–8.
Seccia TM, Miotto D, De Toni R, Pitter G, Mantero F, Pessina AC, et al. Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: comparison of 3 different protocols. Hypertension 2009;53:761–6.
pubmed: 19349554 pmcid: 19349554
Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101:1889–916.
pubmed: 26934393 pmcid: 26934393
Carr CE, Cope C, Cohen DL, Fraker DL, Trerotola SO. Comparison of sequential versus simultaneous methods of adrenal venous sampling. J Vasc Inter Radiol. 2004;15:1245–50.
Rossi GP, Pitter G, Bernante P, Motta R, Feltrin G, Miotto D. Adrenal vein sampling for primary aldosteronism: the assessment of selectivity and lateralization of aldosterone excess baseline and after adrenocorticotropic hormone (ACTH) stimulation. J Hypertens. 2008;26:989–97.
pubmed: 18398342 pmcid: 18398342
Monticone S, Satoh F, Giacchetti G, Viola A, Morimoto R, Kudo M, et al. Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling in primary aldosteronism. Hypertension 2012;59:840–6.
pubmed: 22331382 pmcid: 22331382
Satoh F, Abe T, Tanemoto M, Nakamura M, Abe M, Uruno A, et al. Localization of aldosterone-producing adrenocortical adenomas: significance of adrenal venous sampling. Hypertens Res. 2007;30:1083–95.
pubmed: 18250558 pmcid: 18250558
Morita S, Yamazaki H, Sonoyama Y, Nishina Y, Ichihara A, Sakai S. Successful adrenal venous sampling by non-experts with reference to CT images. Cardiovasc Interv Radiol. 2016;39:1001–6.
Morita S, Nishina Y, Yamazaki H, Sonoyama Y, Ichihara A, Sakai S. Dual adrenal venous phase contrast-enhanced MDCT for visualization of right adrenal veins in patients with primary aldosteronism. Eur Radiol. 2016;26:2073–7.
pubmed: 26494644 pmcid: 26494644
Omura M, Sasano H, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens Res. 2006;29:883–9.
pubmed: 17345788 pmcid: 17345788
Umakoshi H, Tanase-Nakao K, Wada N, Ichijo T, Sone M, Inagaki N, et al. Importance of contralateral aldosterone suppression during adrenal vein sampling in the subtype evaluation of primary aldosteronism. Clin Endocrinol (Oxf). 2015;83:462–7.
Wolley MJ, Gordon RD, Ahmed AH, Stowasser M. Does contralateral suppression at adrenal venous sampling predict outcome following unilateral adrenalectomy for primary aldosteronism? A retrospective study. J Clin Endocrinol Metab. 2015;100:1477–84.
pubmed: 25636049 pmcid: 25636049
Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res. 2009;32:3–107.
pubmed: 19300436 pmcid: 19300436
Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res 2014;37:253–390.
pubmed: 24705419 pmcid: 24705419
Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017;5:689–99.
pubmed: 28576687 pmcid: 28576687
Lefebvre H, Thomas M, Duparc C, Bertherat J, Louiset E. Role of ACTH in the interactive/paracrine regulation of adrenal steroid secretion in physiological and pathophysiological conditions. Front Endocrinol (Lausanne). 2016;7:98.
Steichen O, Amar L. Diagnostic criteria for adrenal venous sampling. Curr Opin Endocrinol Diabetes Obes. 2016;23:218–24.
pubmed: 27119749 pmcid: 27119749
Kita T, Furukoji E, Sakae T, Kitamura K. Efficient screening of patients with aldosterone-producing adenoma using the ACTH stimulation test. Hypertens Res. 2019;42:801–6.
pubmed: 30622316 pmcid: 30622316
Steichen O, Zinzindohoué F, Plouin PF, Amar L. Outcomes of adrenalectomy in patients with unilateral primary aldosteronism: a review. Horm Metab Res. 2012;44:221–7.
pubmed: 22395801 pmcid: 22395801
Bokuda K, Yatabe M, Mizuguchi Y, Niiyama M, Seki Y, Watanabe D, et al. Body mass index and contralateral ratio predict outcome following unilateral adrenalectomy in primary aldosteronism. Hypertens Res. 2017;40:988–93.
pubmed: 28978983 pmcid: 28978983
Umakoshi H, Tsuiki M, Yokomoto-Umakoshi M, Takeda Y, Takashi Y, Kurihara I, et al. Correlation between lateralization index of adrenal venous sampling and standardized outcome in primary aldosteronism. J Endocr Soc. 2018;2:893–902.
pubmed: 30057970 pmcid: 30057970
Shibayama Y, Wada N, Naruse M, Kurihara I, Ito H, Yoneda T, et al. The occurrence of apparent bilateral aldosterone suppression in adrenal vein sampling for primary aldosteronism. J Endocr Soc. 2018;2:398–407.
pubmed: 29687091 pmcid: 29687091

Auteurs

Midori Yatabe (M)

Department of Endocrinology and Hypertension, Tokyo Women's Medical University, Tokyo, Japan. yatabe.midori@twmu.ac.jp.

Kanako Bokuda (K)

Department of Endocrinology and Hypertension, Tokyo Women's Medical University, Tokyo, Japan.

Kaoru Yamashita (K)

Department of Endocrinology and Hypertension, Tokyo Women's Medical University, Tokyo, Japan.

Satoshi Morimoto (S)

Department of Endocrinology and Hypertension, Tokyo Women's Medical University, Tokyo, Japan.

Junichi Yatabe (J)

Department of Endocrinology and Hypertension, Tokyo Women's Medical University, Tokyo, Japan.

Yasufumi Seki (Y)

Department of Endocrinology and Hypertension, Tokyo Women's Medical University, Tokyo, Japan.

Daisuke Watanabe (D)

Department of Endocrinology and Hypertension, Tokyo Women's Medical University, Tokyo, Japan.

Satoru Morita (S)

Department of Diagnostic Imaging and Nuclear Medicine, Tokyo Women's Medical University, Tokyo, Japan.

Shuji Sakai (S)

Department of Diagnostic Imaging and Nuclear Medicine, Tokyo Women's Medical University, Tokyo, Japan.

Atsuhiro Ichihara (A)

Department of Endocrinology and Hypertension, Tokyo Women's Medical University, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH